Tacrolimus is effective in both dual and triple regimens after liver transplantation.
Serrano
J
J
Hospital Virgen del Rocío, Seville, Spain.
García González
M
M
Gómez
M
M
Ortiz de Urbina
J
J
López Cillero
P
P
San Juan
F
F
Parrilla
P
P
Herrero
J I
JI
D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D016031:Liver Transplantation / Q000276:immunology* / Q000401:mortality / Q000502:physiology; D011183:Postoperative Complications / Q000145:classification / Q000453:epidemiology; D012189:Retrospective Studies; D015996:Survival Rate; D016559:Tacrolimus / Q000009:adverse effects / Q000627:therapeutic use*; D013921:Thrombocytopenia / Q000453:epidemiology; D013997:Time Factors
D007166:Immunosuppressive Agents; D016559:Tacrolimus